Bridge City Capital LLC lifted its stake in Plexus Corp. (NASDAQ:PLXS – Free Report) by 0.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,699 shares of the technology company’s stock after buying an additional 238 shares during the quarter. Bridge City Capital LLC owned about 0.10% of Plexus worth $4,178,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also recently made changes to their positions in the company. Pacer Advisors Inc. bought a new stake in Plexus during the 4th quarter worth approximately $107,489,000. Stifel Financial Corp bought a new stake in shares of Plexus during the 3rd quarter valued at $332,000. Barclays PLC lifted its stake in shares of Plexus by 139.4% during the 3rd quarter. Barclays PLC now owns 48,786 shares of the technology company’s stock valued at $6,669,000 after buying an additional 28,406 shares in the last quarter. Verition Fund Management LLC purchased a new position in shares of Plexus during the 3rd quarter valued at $683,000. Finally, FMR LLC boosted its holdings in Plexus by 614.2% in the 3rd quarter. FMR LLC now owns 13,941 shares of the technology company’s stock worth $1,906,000 after buying an additional 11,989 shares during the period. 94.45% of the stock is owned by hedge funds and other institutional investors.
Plexus Price Performance
NASDAQ:PLXS opened at $128.21 on Friday. The company has a market capitalization of $3.47 billion, a P/E ratio of 29.75 and a beta of 0.90. The business’s 50-day moving average is $140.08 and its 200 day moving average is $145.55. The company has a current ratio of 1.53, a quick ratio of 0.70 and a debt-to-equity ratio of 0.07. Plexus Corp. has a 12 month low of $90.87 and a 12 month high of $172.89.
Wall Street Analyst Weigh In
Several equities analysts have recently commented on the company. Stifel Nicolaus started coverage on Plexus in a research report on Tuesday, February 4th. They issued a “hold” rating and a $152.00 price objective on the stock. Needham & Company LLC boosted their price target on Plexus from $162.00 to $172.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Finally, Benchmark reaffirmed a “buy” rating and set a $165.00 price objective on shares of Plexus in a report on Wednesday, January 22nd. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, Plexus currently has a consensus rating of “Moderate Buy” and a consensus price target of $163.00.
View Our Latest Stock Analysis on PLXS
Insider Transactions at Plexus
In other Plexus news, insider Michael J. Running sold 1,250 shares of the business’s stock in a transaction that occurred on Friday, February 21st. The stock was sold at an average price of $138.62, for a total transaction of $173,275.00. Following the sale, the insider now directly owns 1,276 shares of the company’s stock, valued at $176,879.12. The trade was a 49.49 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Todd P. Kelsey sold 4,337 shares of the firm’s stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $142.23, for a total value of $616,851.51. Following the completion of the sale, the chief executive officer now directly owns 80,595 shares of the company’s stock, valued at $11,463,026.85. The trade was a 5.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 19,458 shares of company stock worth $2,786,515 in the last three months. Insiders own 1.76% of the company’s stock.
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More
- Five stocks we like better than Plexus
- How to Invest in the Best Canadian StocksĀ
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- About the Markup Calculator
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- When to Sell a Stock for Profit or Loss
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.